Eugenia Wachters, Msc, Mba
AeroLeads people directory · profile

Eugenia Wachters, Msc, Mba Email & Phone Number

COO at ProFactor Pharma at PROFACTOR PHARMA LTD
Location: Guildford, England, United Kingdom 15 work roles 3 schools
1 work email found @profactorpharma.com 3 phones found area 148 and 207 LinkedIn matched
✓ Verified August 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 3 phones

Work email e****@profactorpharma.com
Direct phone (148) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
COO at ProFactor Pharma
Location
Guildford, England, United Kingdom

Who is Eugenia Wachters, Msc, Mba? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Eugenia Wachters, Msc, Mba is listed as COO at ProFactor Pharma at PROFACTOR PHARMA LTD, based in Guildford, England, United Kingdom. AeroLeads shows a work email signal at profactorpharma.com, phone signal with area code 148, 207, and a matched LinkedIn profile for Eugenia Wachters, Msc, Mba.

Eugenia Wachters, Msc, Mba previously worked as COO at Profactor Pharma Ltd and VP Commercial & Operations at Healx. Eugenia Wachters, Msc, Mba holds In Company Program Sanofi ''Leading For Tomorrow'' from Duke University.

Company email context

Email format at PROFACTOR PHARMA LTD

This section adds company-level context without repeating Eugenia Wachters, Msc, Mba's masked contact details.

*@profactorpharma.com
68% confidence

AeroLeads found 1 current-domain work email signal for Eugenia Wachters, Msc, Mba. Compare company email patterns before reaching out.

Profile bio

About Eugenia Wachters, Msc, Mba

Impactful C-level executive in Pharma/Biotech with a deep expertise in developing commercial strategies and driving business operations. Extensive leadership experience in global corporate pharma companies as well as in small, pre-revenue (preclinical/clinical stage) biotech companies. Solid understanding across the wider pharma business, from (AI driven) drug discovery to clinical development, market access & reimbursement through to commercialization. Experience in working with Boards, fundraising (series A & B) and developing external partnerships.Successfully managed the P&L of £100M+ product portfolios, across the product life cycle, in both EU and emerging markets, leading large commercial teams.Solid knowledge across wide range of therapeutic areas including rare diseases. Track record of delivering excellent business results, recognized for ‘getting things done’. Operating with an analytical, strategic mindset, yet a pragmatic ‘can do’ approach. Passionate about developing & growing businesses and driving organizational effectiveness. Dynamic leadership, open communication, with a challenge of the status quo. Thriving in an international, multi-cultural environment and smaller organizations, with a highly cross-functional culture.Key capabilities:Commercial strategy | Business Operations | P&L management | Transformational leadership

Listed skills include Market Analysis, Strategy, Management, Lifesciences, and 13 others.

Current workplace

Eugenia Wachters, Msc, Mba's current company

Company context helps verify the profile and gives searchers a useful next step.

PROFACTOR PHARMA LTD
Profactor Pharma Ltd
COO at ProFactor Pharma
AeroLeads page
15 roles · 35 years

Eugenia Wachters, Msc, Mba work experience

A career timeline built from the work history available for this profile.

Coo

Current

Edinburgh, Midlothian, Gb

ProFactor Pharma is a (pre)clinical biotech company developing a blood clotting factor replacement therapy (recombinant Factor FVIII) for Haemophilia A. As Chief Operating Officer and only full-time employed employee, I am responsible for developing the overall Business Strategy, defining key target markets and building new new partnerships, as well as working closely with the (part-time) CEO and Chairman of the Board on fundraising (Series A). I also drive the operational aspects of the business.

Jul 2023 - Present

Vp Commercial & Operations

Cambridge, Cambridgeshire, Gb

- Providing the Commercial leadership, driving the Portfolio Strategy and the Commercial Strategy of individual assets under development- Calculation of Portfolio/Company valutions and contributing to investor pitches (Series C).- Leading the development of the Portfolio Operations; building out the Operations team & activities

Nov 2021 - Jul 2023

Vp Commercial Portfolio Strategy

Cambridge, Cambridgeshire, Gb

Providing the commercial leadership for Healx, driving the overall commercial portfolio strategy and the commercial strategy of individual assets under development.

Dec 2020 - Jan 2022

Interim Management Consultant Commercial Strategy

Cambridge, Cambridgeshire, Gb

Worked on the development of the Portfolio Strategy, including development of a process & tool for the valuation of early (pre)clinical assets and total portfolio over time to drive strategic portfolio decision making. Led commercial assessments & recommendations for disease & drug candidate selection and competitive intelligence insights.Achievements: presented outputs of the Healx Portfolio Strategy Modelling to the Board (June/Sept 2020) and delivered an internal decision-making process for progression of development assets from drug discovery to the clinic.

May 2020 - Dec 2020

Travel Sabbatical, Consultancy & Volunteering Work

Travelling around the world from Dec 2018 - July 2019Consultancy (Oct '18, advising MMRG's on their Thecosystem target clients and pricing strategy) and Healx (Feb '19 - April '19, diverse Commercial strategy consultancy projects).Volunteering work (Aug '19 - Jan '19), working for Findacure, a UK-based charity which aims to develop a support system to help patient groups grow and professionalise their work and support the development of treatments and build public awareness of rare diseases. I delivered a proposal how to increase revenue income from new and existing activities (fund raising and other) so that Findacure can expand its support in helping Rare Disease Patient organizations to thrive.

Nov 2018 - Apr 2020

General Manager Uk (General Medicines)

Paris, France, Fr

As General Manager UK, led the Business transformation strategy for the Established products business, consisting of approx. 70 brands, implementing an innovative multi-channel customer engagement model and a targeted portfolio strategy Key TA's: Thrombosis, Epilepsy/Bipolar, HypercholesterolemiaKey achievements:- Realized a turn-around of the business performance, reversing a declining sales into flat sales and improving the profitability (working all lines of the P&L) through a focused Portfolio strategy, an improved Trade & Pricing strategy, the implementation of a new, multi-channel promotional model and driving Excellence in Execution.- Transformed the BU in an attractive place to work, with a learning culture, room for pioneering, innovation and stimulated internal promotions

Feb 2017 - Oct 2018

Vice President Commercial Operations For Emerging Markets

Paris, France, Fr

As Business partner for the Sr VP of the Emerging Markets Region (Russia & Central Asia, Africa, Turkey, Middle East and India), responsible for driving the Regional Portfolio-, Brand-, Launch- and Market Access strategy across the portfolio (Diabetes, Cardiovascular/Established products, Oncology). Also in charge of ensuring Commercial Excellence, identifying areas for marketing & sales force improvements across the region, and leading monthly commercial performance reviews.Key achievements:- Achieved 3 consecutive years of double-digit growth (≥15%) of the Diabetes business, working closely with country GMs and BU heads on optimizing their strategic plans- Delivered a regional Launch plan (key countries, launch sequence/timing) for new products - (Toujeo/Lyxumia/Lixilan/Praluent/Zaltrap-Jevtana), line extensions and geo expansion as part of the 10-yr strategic plan, and rolled out a Launch Excellence framework.- Successfully supported several countries on launch readiness, including the right brand- and market access strategy and price setting for Toujeo and Praluent.- Drove the implementation of Digital Marketing & a multi-channel customer engagement approach (including remote edetailing in areas difficult to reach by reps) across the region.

Nov 2013 - Jan 2017

General Manager The Netherlands And Business Unit Director Benelux

Paris, France, Fr

As Country manager leading the Dutch organization (€130M turnover, 110 employees) as well as driving the Benelux Marketing strategy for the Cardiovascular, Renal & Bio-surgery portfolio.

Apr 2012 - Oct 2013

Business Unit Director Benelux

Paris, France, Fr

Led the commercial & marketing strategy of the Cardiovascular, Thrombosis and Neurology/MS portfolio across the Benelux

May 2011 - Mar 2012

Director Business Management & Support

Paris, France, Fr

In charge of ensuring ‘business excellence’ in all commercial activities of the affiliate (Market analysis, Market research, Marketing excellence, Sales Force effectiveness, Business planning)

Oct 2005 - Apr 2011

Global Marketing Excellence Manager

Paris, France, Fr

Developed Marketing Excellence frameworks to increase and align marketing capabilities & skills globally.

May 2004 - Sep 2005

District Sales Manager

Paris, France, Fr

Aug 2003 - Apr 2004

Group Product Manager Cardiovascular

Paris, France, Fr

Driving the launch of Aprovel (in JV with BMS)

Feb 2001 - Jul 2003

Product Manager Cardiovascular/Neurology

Ingelheim Am Rhein, Rhineland-Palatinate, De

1998 - Jan 2001

Rayon Manager (Respiratory)

Gsk

Brentford, Middlesex, Gb

1992 - 1998 ~6 yrs
3 education records

Eugenia Wachters, Msc, Mba education

In Company Program Sanofi ''Leading For Tomorrow''

Duke University

Executive Mba

Rotterdam School Of Management, Erasmus University

Drs, Biology (Molecular Biology)

Leiden University
FAQ

Frequently asked questions about Eugenia Wachters, Msc, Mba

Quick answers generated from the profile data available on this page.

What company does Eugenia Wachters, Msc, Mba work for?

Eugenia Wachters, Msc, Mba works for PROFACTOR PHARMA LTD.

What is Eugenia Wachters, Msc, Mba's role at PROFACTOR PHARMA LTD?

Eugenia Wachters, Msc, Mba is listed as COO at ProFactor Pharma at PROFACTOR PHARMA LTD.

What is Eugenia Wachters, Msc, Mba's email address?

AeroLeads has found 1 work email signal at @profactorpharma.com for Eugenia Wachters, Msc, Mba at PROFACTOR PHARMA LTD.

What is Eugenia Wachters, Msc, Mba's phone number?

AeroLeads has found 3 phone signal(s) with area code 148, 207 for Eugenia Wachters, Msc, Mba at PROFACTOR PHARMA LTD.

Where is Eugenia Wachters, Msc, Mba based?

Eugenia Wachters, Msc, Mba is based in Guildford, England, United Kingdom while working with PROFACTOR PHARMA LTD.

What companies has Eugenia Wachters, Msc, Mba worked for?

Eugenia Wachters, Msc, Mba has worked for Profactor Pharma Ltd, Healx, Ewconsultancy, Sanofi, and Boehringer Ingelheim.

How can I contact Eugenia Wachters, Msc, Mba?

You can use AeroLeads to view verified contact signals for Eugenia Wachters, Msc, Mba at PROFACTOR PHARMA LTD, including work email, phone, and LinkedIn data when available.

What schools did Eugenia Wachters, Msc, Mba attend?

Eugenia Wachters, Msc, Mba holds In Company Program Sanofi ''Leading For Tomorrow'' from Duke University.

What skills is Eugenia Wachters, Msc, Mba known for?

Eugenia Wachters, Msc, Mba is listed with skills including Market Analysis, Strategy, Management, Lifesciences, Oncology, Crm, Change Management, and Market Access.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.